1. Springer C, Salen P. Gonorrhea. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK558903/
2. Qureshi S. Gonorrhea: Practice Essentials, Background, Pathophysiology. Medscape, 2021. https://emedicine.medscape.com/article/218059-overview#a1
3. Unemo M, Seifert HS, Hook EW, Hawkes S, Ndowa F, Dillon JAR. Gonorrhoea. Nat Rev Dis Primer. 2019 Nov 21;5(1):1–23.
4. St. Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection. Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1911–6.
5. Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol. 2018 Apr;16(4):226–40.
6. Newman CR, Joshi K, Brucks E, Ferreira JP. Disseminated Gonococcal Infection in an Immunosuppressed Patient. Am J Med. 2021 Feb 1;134(2):e123–4.
7. Crew PE, Abara WE, McCulley L, Waldron PE, Kirkcaldy RD, Weston EJ, et al. Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series. Clin Infect Dis. 2019 Aug 1;69(4):596–600.
8. Merrick R, Pitt R, Enayat Q, Day M, Thorn L, Mohammed H, et al. National surveillance of disseminated gonococcal infection: preliminary findings from cross-sectional survey data in England, 2016–21. The Lancet. 2021 Nov 1;398:S65.

15. Suay-García B, Pérez-Gracia MT. Future Prospects for Neisseria gonorrhoeae Treatment. Antibiotics. 2018 Jun 15;7(2):49.
16. WHO. Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (‎syphilis)‎ and new recommendations on syphilis testing and partner services. 2024. https://www.who.int/publications/i/item/9789240090767
17. Qureshi S. What should be included in patient education about gonorrhea? Medscape. 2021. https://www.medscape.com/answers/218059-68159/what-should-be-included-in-patient-education-about-gonorrhea
18. Kirkcaldy RD, Zaidi A, Hook EW 3rd, Holmes KK, Soge O, del Rio C, Hall G, Papp J, Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis 2017; 17:e235.
19. Brittain C, Childs M, Duley L, et al. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. Trials 2016; 17:558.
20. Quaye N, Cole MJ, Ison CA. Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime. J Antimicrob Chemother 2014; 69:1568.
21. Eyre DW, Sanderson ND, Lord E, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill 2018; 23.
22. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7:1401.
23. Bolan G, Weinstock HS. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med. 2013;158(5 Pt 1):321.